Steven D. Weiner (Moderator)

Steven D. Weiner (Moderator)

Kaufman, Borgeest & Ryan, LLP

Senior Partner

Steven is a partner who focuses his practice in the defense of matters involving Toxic Torts, Pharmaceuticals, Products Liability, Medical Malpratice and Skilled Nursing, Assisted Living, Home Care & Hospice. Steven has represented product manufactures and premises owners in asbestos litigation for the past 20 years. Steven serves as national supervisory and coordinating counsel for major asbestos manufacturers, and in that capacity has overseen thousands of cases filed in various state and federal courts throughout the country, as well as Multi-District Litigation matters. He has given various lectures in respect to his vast experience in the asbestos litigation and specific defense of his clients.

A licensed pharmacist, Steven devotes a substantial portion of his time to the defense of physicians and hospitals and related entities. Steven also focuses extensively on the defense of Nursing Homes, both nationally and locally. In this capacity, he has served as both supervisory/monitoring counsel and as trial counsel. In addition, he has lectured considerably to the insurance industry, as well as provided numerous in-service lectures to Nursing Homes in matters pertaining to the defense of Nursing Homes.

Steven has utilized his pharmaceutical and science background to offer insightful advice to clients in the areas of toxic substances and mass tort litigation. He has also lectured to representatives of the insurance industry and defense counsel on a variety of topics, including mold, latex and lead paint. Steven’s pharmaceuticals experience ranges from the defense of actions pertaining to the clinical trial phase to post-marketed drugs and medical devices.

Steven’s focus throughout his career has included the defense of product manufacturers, attorney, psychiatric and dental malpractice actions, as well as other tort matters and related coverage disputes. He has also lectured on such issues and has provided risk management advice to companies engaged in drug clinical trials.

In light of his national experience and reputation, Steven has been invited to join the prestigious International Association of Defense Counsel.